For many parents of kids under age 5, a safe and effective COVID-19 vaccine could not come soon enough. A full year and a half after shots first became available for adults, their wait is nearly over.
On June 17, 2022, the Food and Drug Administration authorized both the Pfizer-BioNTech and Moderna COVID-19 shots for the nearly 20 million U.S. children between the ages of 6 months and 4 years. The widely anticipated decision follows a unanimous recommendation in favor of the shots by the FDA’s independent advisory panel.
